204 related articles for article (PubMed ID: 24170386)
1. High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice.
Lehti M; Donelan E; Abplanalp W; Al-Massadi O; Habegger KM; Weber J; Ress C; Mansfeld J; Somvanshi S; Trivedi C; Keuper M; Ograjsek T; Striese C; Cucuruz S; Pfluger PT; Krishna R; Gordon SM; Silva RA; Luquet S; Castel J; Martinez S; D'Alessio D; Davidson WS; Hofmann SM
Circulation; 2013 Nov; 128(22):2364-71. PubMed ID: 24170386
[TBL] [Abstract][Full Text] [Related]
2. Circulating HDL levels control hypothalamic astrogliosis via apoA-I.
Götz A; Lehti M; Donelan E; Striese C; Cucuruz S; Sachs S; Yi CX; Woods SC; Wright SD; Müller TD; Tschöp MH; Gao Y; Hofmann SM
J Lipid Res; 2018 Sep; 59(9):1649-1659. PubMed ID: 29991652
[TBL] [Abstract][Full Text] [Related]
3. Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.
Xepapadaki E; Maulucci G; Constantinou C; Karavia EA; Zvintzou E; Daniel B; Sasson S; Kypreos KE
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1351-1360. PubMed ID: 30742993
[TBL] [Abstract][Full Text] [Related]
4. Genetically increasing flux through β-oxidation in skeletal muscle increases mitochondrial reductive stress and glucose intolerance.
Smith CD; Lin CT; McMillin SL; Weyrauch LA; Schmidt CA; Smith CA; Kurland IJ; Witczak CA; Neufer PD
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E938-E950. PubMed ID: 33813880
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoprotein: a new therapeutic target for glucose intolerance?
Mortensen SP; Boushel R
Circulation; 2013 Nov; 128(22):2349-50. PubMed ID: 24170387
[No Abstract] [Full Text] [Related]
6. HDL-C and apolipoprotein A-I are independently associated with skeletal muscle mitochondrial function in healthy humans.
Giacona JM; Petric UB; Kositanurit W; Wang J; Saldanha S; Young BE; Khan G; Connelly MA; Smith SA; Rohatgi A; Vongpatanasin W
Am J Physiol Heart Circ Physiol; 2024 Apr; 326(4):H916-H922. PubMed ID: 38334968
[TBL] [Abstract][Full Text] [Related]
7. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance.
Castellani LW; Goto AM; Lusis AJ
Diabetes; 2001 Mar; 50(3):643-51. PubMed ID: 11246886
[TBL] [Abstract][Full Text] [Related]
8. High density lipoprotein protects against polymicrobe-induced sepsis in mice.
Guo L; Ai J; Zheng Z; Howatt DA; Daugherty A; Huang B; Li XA
J Biol Chem; 2013 Jun; 288(25):17947-53. PubMed ID: 23658016
[TBL] [Abstract][Full Text] [Related]
9. In vivo PET imaging with [(18)F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes.
Cochran BJ; Ryder WJ; Parmar A; Tang S; Reilhac A; Arthur A; Charil A; Hamze H; Barter PJ; Kritharides L; Meikle SR; Gregoire MC; Rye KA
Diabetologia; 2016 Sep; 59(9):1977-84. PubMed ID: 27193916
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunction and inhibition of myoblast differentiation in mice with high-fat-diet-induced pre-diabetes.
Xu D; Jiang Z; Sun Z; Wang L; Zhao G; Hassan HM; Fan S; Zhou W; Han S; Zhang L; Wang T
J Cell Physiol; 2019 May; 234(5):7510-7523. PubMed ID: 30362548
[TBL] [Abstract][Full Text] [Related]
11. ApoA-1 improves glucose tolerance by increasing glucose uptake into heart and skeletal muscle independently of AMPKα
Fritzen AM; Domingo-Espín J; Lundsgaard AM; Kleinert M; Israelsen I; Carl CS; Nicolaisen TS; Kjøbsted R; Jeppesen JF; Wojtaszewski JFP; Lagerstedt JO; Kiens B
Mol Metab; 2020 May; 35():100949. PubMed ID: 32244181
[TBL] [Abstract][Full Text] [Related]
12. Safe and sustained overexpression of functional apolipoprotein A-I/high-density lipoprotein in apolipoprotein A-I-null mice by muscular adeno-associated viral serotype 8 vector gene transfer.
Cimmino G; Chen W; Speidl WS; Giannarelli C; Ibanez B; Fuster V; Hajjar R; Walsh CE; Badimon JJ
J Cardiovasc Pharmacol; 2009 Nov; 54(5):405-11. PubMed ID: 19701094
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus.
Drew BG; Duffy SJ; Formosa MF; Natoli AK; Henstridge DC; Penfold SA; Thomas WG; Mukhamedova N; de Courten B; Forbes JM; Yap FY; Kaye DM; van Hall G; Febbraio MA; Kemp BE; Sviridov D; Steinberg GR; Kingwell BA
Circulation; 2009 Apr; 119(15):2103-11. PubMed ID: 19349317
[TBL] [Abstract][Full Text] [Related]
14. Single injections of apoA-I acutely improve in vivo glucose tolerance in insulin-resistant mice.
Stenkula KG; Lindahl M; Petrlova J; Dalla-Riva J; Göransson O; Cushman SW; Krupinska E; Jones HA; Lagerstedt JO
Diabetologia; 2014 Apr; 57(4):797-800. PubMed ID: 24442447
[TBL] [Abstract][Full Text] [Related]
15. Deficiency in apolipoprotein A-I ablates the pharmacological effects of metformin on plasma glucose homeostasis and hepatic lipid deposition.
Karavia EA; Hatziri A; Kalogeropoulou C; Papachristou NI; Xepapadaki E; Constantinou C; Natsos A; Petropoulou PI; Sasson S; Papachristou DJ; Kypreos KE
Eur J Pharmacol; 2015 Nov; 766():76-85. PubMed ID: 26420354
[TBL] [Abstract][Full Text] [Related]
16. Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice.
Tiniakou I; Kanaki Z; Georgopoulos S; Chroni A; Van Eck M; Fotakis P; Zannis VI; Kardassis D
Atherosclerosis; 2015 Nov; 243(1):77-85. PubMed ID: 26363436
[TBL] [Abstract][Full Text] [Related]
17. Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism.
Domingo-Espín J; Nilsson O; Bernfur K; Del Giudice R; Lagerstedt JO
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2822-2834. PubMed ID: 29802959
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.
Lewis TL; Cao D; Lu H; Mans RA; Su YR; Jungbauer L; Linton MF; Fazio S; LaDu MJ; Li L
J Biol Chem; 2010 Nov; 285(47):36958-68. PubMed ID: 20847045
[TBL] [Abstract][Full Text] [Related]
19. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins.
Qin S; Kawano K; Bruce C; Lin M; Bisgaier C; Tall AR; Jiang X
J Lipid Res; 2000 Feb; 41(2):269-76. PubMed ID: 10681411
[TBL] [Abstract][Full Text] [Related]
20. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.
Silver DL; Jiang XC; Tall AR
J Biol Chem; 1999 Feb; 274(7):4140-6. PubMed ID: 9933608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
